UCF researchers develop nanoparticle microbe testing

Found a neat article hear discussing a new nanoparticle technology being developed by University of Central Florida researchers.  The technology will allow doctors to test for hard to find microbes that can lie dormant deep inside tissue of humans for years before reactivating themselves and causing harm to the human body.  A common example of this appears in tuberculosis cases.

The researchers tested their product against Mycobacterium avium paratuberculosis (MAP), a pathogen that has been linked to the cause of Johne’s Disease in cattle which is similar to Crohn’s Disease in humans.  This is good stuff, it could lead to a new therapy, better testing for Crohn’s in humans, or even a cure to Crohn’s Disease in the future.

University of Central Florida appears to be very active in diseases of the intestine, note another article we covered before about UCF researchers developing a new blood test for Crohn’s which they patented and then sold to a pharmaceutical company.  I was pretty critical of the researchers doing that as it appears that the science is not about the money, only how much, sort of like in politics and just about anything else nowadays I suppose.

Crohn’s Disease drug maker Prometheus cannot patent a law of nature

Found interesting coverage here and here about a Prometheus patent that was thrown out based on the ruling that the laws of nature cannot be patented.  The Supreme Court threw out medical patent claims by Prometheus Laboratories that sought to tailor drugs to Crohn’s Disease patients based on a blood test.  The blood test measures the rate that medicine breaks down upon metabolizing in individual patients.  This ruling is a pretty big deal in the circles of personalized medicine and directly relates to Crohn’s Disease.  Prometheus sued the Mayo Clinic for patent infringement after the Mayo Clinic developed their own version of the blood test.  My take on the decision is that the lower cost of health care for patients based on the existence of multiple tests is a good thing.

New blood test for MAP patented, sold, then buried in the sand…

Read this or this if you want to know what is wrong with the world…  If you do not feel like reading the articles here is a summary.  Researchers at the University of Central Florida discovered a new way to test the bloodstream for MAP (a bacteria) frequently found in Crohn’s Disease patients.  Now instead of simply publishing the results in a peer reviewed journal where the world can benefit from this new knowledge and the researchers can add another notch in the old curriculum vitae, the researchers patented the test and then sold the patent rights to a big pharmaceutical company in Israel for them to use in their own medicine research.

So what? Well, so what is now the cost of that test will go into the price of the medication that the company is producing, and that cost gets passed onto Crohn’s Disease patients.  Not to mention that this new technology will not be useful to others researching Crohn’s Disease.

“Patients will benefit the most because of this breakthrough since it will advance the diagnosis and treatment of Crohn’s disease,” Naser said of the diagnostic technology he created.

I don’t agree, patients would benefit the most if the technology were not patented and then said patent were not sold to a big pharma company.